they had a much increased sex drive compared to before they used the patch

A report which was recently published in the respected Journal of Sexual Medicine has looked at the effects of the new female sexual dysfunction patch called Intrinsa. Intrinsa which is being nicknamed the female Viagra works by giving women a boost of the male hormone testosterone which is sometimes lacking in women who have a low libido.

The new report which was written up by Dr. Sheryl Kingsberg looked at over 130 women who said that their desire to have sex was greatly reduced after they lost their ovaries. When women to lose their ovaries they tend to immediately produce less of three important hormones namely estrogen, progesterone and testosterone which causes them in turn to experience menopause.

The new report which was written up by Dr. Sheryl Kingsbergtheir desire to have sexwas greatly reduced after they lost.When women to lose their ovarieshormones namely estrogen, progesterone and testosterone whichturn to experience menopause.What is interesting about the research is that the women who were split into two different groups and either received a testosterone boost through the Intrinsa patch or they were given a placebo patch which did not contain any testosterone. It was noted that some of the women who were given the placebo patch reported an increase in sexual desire but not as many as the women who were given the real Intrinsa patch.

The clinical results showed that just over 50 percent of the women who used the Intrinsa patch said that they had had more satisfying sexual relations and that they had a much increased sex drive compared to before they used the patch. The clinical results for the women who used the placebo patch showed that 31 percent of women reported the same. If you ever need proof that a lot of what we feel from a sexual point of view is in your head you should consider this research and the results of research done with men using placebo Viagra tablets. The positive placebo effect of sexual dysfunction medication can sometimes be experienced by as many as 40 percent of participants.